首页>
外国专利>
COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
展开▼
机译:尼罗替尼和氯丁酸联合治疗慢性淋巴细胞性白血病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a combination which comprises (a) a DNA damaging agent; and (b) 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide (nilotinib); a pharmaceutical composition comprising such a combination and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment chronic lymphocytic leukemia (CLL); the use of such a combination for the preparation of a medicament for the treatment of CLL; a commercial package or product comprising such a combination; and to a method of treatment of a warm-blooded animal, especially a human.
展开▼